An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
Clinical trial NCT01610713 · COMPLETED
Trial details
- NCT number
- NCT01610713
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Primary completion
- 2002-07-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.